Search Browse Earnings

AN2 Therapeutics, Inc. — SlamSEC

AN2 Therapeutics, Inc.

Nasdaq:ANTX

Pharmaceutical Preparations·MENLO PARK, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$64.7M

FY 2024

EPS (Diluted)

-$2.74

FY 2024

Stock Price

$4.94

-9.2%

2026-03-13

52W Range

$1.00 – $6.91

P/E Ratio

-1.8x

Market Cap

$135.4M

Cash

$15.6M

FY 2024

Total Debt

—

Net Cash

$15.6M

Enterprise Value

$119.7M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—